Tag ~juno therapeutics

Tag descriptions coming soon to Wherrelz News!

geekwire
Why Celgene decided to buy Juno Therapeutics for 9B with a little help from US tax reform
geekwire
Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene
geekwire
Celgene CEO: Treating cancer is becoming ironically easy now the problem is affordability
geekwire
Juno Therapeutics acquired by Celgene for 9B in dramatic deal for rising biotech star
geekwire
Juno Therapeutics agrees to pay 24M to stockholders in suit over disclosure of patient deaths
geekwire
Led by former Juno execs Sana is a new cell engineering biotech thats reportedly raising more than 800M
geekwire
Longtime Juno Therapeutics CEO Hans Bishop leaves role after merger with Celgene
geekwire
Week in Geek Podcast: A 9B biotech deal and a look at Pittsburghs tech renaissance
geekwire
Juno Therapeutics stock surges 50 as Celgene is reportedly in talks to buy the company
geekwire
BristolMyers Squibb exec on how can Seattle grow and keep big biotech companies
techcrunch
Home run exits happen stealthily for biotech
geekwire
Tech moves: Groupon adds former Amazon VP as CTO Juno expands executive team and more
geekwire
Tech Moves: Hillel Cooperman named SVP at Oracle Seattle architecture leader Karen Thomas promoted at Gensler CrowdCow taps startup vet Fioca etc
geekwire
Seattlebased Shape Therapeutics raises 112M to develop RNAediting and gene therapies
geekwire
Tech Moves: Microsoft vets move to Amazon NurseGrid expands executive team and more
geekwire
Juno finds clinical success with cancer drug beats analyst expectations with 44M in revenue
geekwire
Cell therapies are giving Seattle an edge in biotech driving three acquisitions in under a month
geekwire
Former Juno execs unveil Sana a new cell engineering biotech thats reportedly raising more than 800M
geekwire
BristolMyers Squibbs 74B acquisition of Juno parent Celgene puts Seattle biotech world on alert